Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability

Journal of Cerebral Blood Flow and Metabolism

Volumn 34, Issue 1, 2014, Pages 34-42

  Paling, David ^a   Thade Petersen, Esben ^b   Tozer, Daniel J ^b   Altmann, Daniel R ^a,c   Wheeler Kingshott, Claudia A M ^a   Kapoor, Raju ^a   Miller, David H ^a   Golay, Xavier ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

hemodynamics; inflammation; magnetic resonance imaging; multiple sclerosis; perfusion imaging; relapsingremitting

Indexed keywords

ADULT; AGED; ARTERIAL SPIN LABELING MAGNETIC RESONANCE IMAGING; ARTICLE; ATROPHY; BRAIN BLOOD FLOW; CEREBRAL ARTERIAL BOLUS ARRIVAL TIME; CIRCULATION TIME; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP GRAY MATTER; DISABILITY; DISEASE ASSOCIATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HEMODYNAMIC PARAMETERS; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NORMAL APPEARING WHITE MATTER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; WHITE MATTER; YOUNG ADULT;

EID: 84891831182     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.161     Document Type: Article

References (40)

1. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-2712.
2. Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 2008; 131: 288-303.
3. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009; 132: 1175-1189.
4. Howell OW, Rundle JL, Garg A, Komada M, Brophy PJ, Reynolds R. Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J Neurol Neurosurg Psychiatr 2010; 69: 1017-1033.
5. Soon D, Tozer DJ, Altmann DR, Tofts PS, Miller DH. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Mult Scler 2007; 13: 884-894.
6. Plumb J, McQuaid S, Mirakhur M, Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 2002; 12: 154-169.
7. Haider L, Fischer MT, Frischer JM, Bauer J, Höftberger R, Botond G et al. Oxidative damage in multiple sclerosis lesions. Brain 2011; 134: 1914-1924.
8. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 2005; 128: 1016-1025.
9. Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, Villringer A et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004; 127: 111-119.
10. Broom KA, Anthony DC, Blamire AM, Waters S, Styles P, Perry VH et al. MRI reveals that early changes in cerebral blood volume precede blood-brain barrier breakdown and overt pathology in MS-like lesions in rat brain. J Cereb Blood Flow Metab 2005; 25: 204-216.
11. Serres S, Anthony DC, Jiang Y, Broom KA, Campbell SJ, Tyler DJ et al. Systemic inflammatory response reactivates immune-mediated lesions in rat brain. J Neurosci 2009; 29: 4820-4828.
12. Serres S, Bristow C, de Pablos RM, Merkler D, Soto MS, Sibson NR et al. Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis. J Cereb Blood Flow Metab 2013; 33: 744-753.
13. Boas DA, Jones SR, Devor A, Huppert TJ, Dale AM. A vascular anatomical network model of the spatio-temporal response to brain activation. Neuroimage 2008; 40: 1116-1129.
14. Mancini M, Morra VB, Di Donato O, Maglio V, Lanzillo R, Liuzzi R et al. Multiple sclerosis: cerebral circulation time. Radiology 2012; 262: 947-955.
15. Law M, Saindane AM, Ge Y, Babb JS, Johnson G, Mannon LJ et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 2004; 231: 645-652.
16. Ge Y, Law M, Johnson G, Herbert J, Babb JS, Mannon LJ et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol 2005; 26: 1539-1547.
17. Garaci FG, Marziali S, Meschini A, Fornari M, Rossi S, Melis M et al. Brain hemo-dynamic changes associated with chronic cerebrospinal venous insufficiency are not specific to multiple sclerosis and do not increase its severity. Radiology 2012; 265: 233-239.
18. Liu Y, Zhu X, Feinberg D, Guenther M, Gregori J, Weiner MW et al. Arterial spin labeling MRI study of age and gender effects on brain perfusion hemodynamics. Magn Reson Med 2012; 68: 912-922.
19. Petersen E, Lim T, Golay X. Model-free arterial spin labeling quantification approach for perfusion MRI. Magn Reson Med 2006; 55: 219-232.
20. Yoshiura T, Hiwatashi A, Noguchi T, Yamashita K, Ohyagi Y, Monji A et al. Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer's disease. Eur Radiol 2009; 19: 2819-2825.
21. Petersen ET, Mouridsen K, Golay X. The QUASAR reproducibility study, part II: results from a multi-center arterial spin labeling test-retest study. Neuroimage 2010; 49: 104-113.
22. Mak HKF, Chan Q, Zhang Z, Petersen ET, Qiu D, Zhang L et al. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal elderly adults at 3-Tesla. J Alzheimers Dis 2012; 31: 33-44.
23. Qiu M, Maguire RP, Arora J, Planeta-Wilson B, Weinzimmer D, Wang J et al. Arterial transit time effects in pulsed arterial spin labeling CBF mapping: insight from a PET and MR study in normal human subjects. Magn Reson Med 2010; 63: 374-384.
24. Rashid W, Parkes LM, Ingle GT, Chard DT, Toosy AT, Altmann DR et al. Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatry 2004; 75: 1288-1293.
25. Polman C, Reingold S, Banwell B, Clanet M, Cohen J, Filippi M et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
26. Kurtzke JF. Rating neurologic impairment in multiple sclerosis. Neurology 1983; 33: 1444-1452.
27. Ourselin S, Roche A, Subsol G, Pennec X, Ayache N. Reconstructing a 3D structure from serial histological sections. Image Vision Comput 2001; 19: 25-31.
28. Ourselin S, Stefanescu R, Pennec X. Robust registration of multi-modal images: towards real-time clinical applications. MICCAI 2002; 2489: 140-147.
29. Tahmasebi AM, Abolmaesumi P, Wild C, Johnsrude IS. A validation framework for probabilistic maps using Heschl's gyrus as a model. Neuroimage 2010; 50: z532-544.
30. Hendrikse J, Petersen E, van Laar P, Golay X. Cerebral border zones between distal end branches of intracranial arteries: MR imaging. Radiology 2008; 246: 572-580.
31. Rejdak K, Eikelenboom MJ, Petzold A, Thompson EJ, Stelmasiak Z, Lazeron RHC et al. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology 2004; 63: 1439-1445.
32. Inglese M, Liu S, Babb JS, Mannon LJ, Grossman RI, Gonen O. Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing-remitting MS. Neurology 2004; 63: 170-172.
33. Amann M, Achtnichts L, Hirsch JG, Naegelin Y, Gregori J, Weier K et al. 3D GRASE arterial spin labelling reveals an inverse correlation of cortical perfusion with the white matter lesion volume in MS. Mult Scler 2012; 18: 1570-1576.
34. Darwish RS, Amiridze NS. Brain perfusion abnormalities in patients with compromised venous outflow. J Neurol 2011; 258: 1445-1450.
35. Adhya S, Johnson G, Herbert J, Jaggi H, Babb JS, Grossman RI et al. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 2006; 33: 1029-1035.
36. Inglese M, Adhya S, Johnson G, Babb JS, Miles L, Jaggi H et al. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab 2008; 28: 164-171.
37. Inglese M, Park S-J, Johnson G, Babb JS, Miles L, Jaggi H et al. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol 2007; 64: 196-202.
38. Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M. White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J Neurol Sci 2009; 282: 28-33.
39. Paling D, Golay X, Wheeler-Kingshott C, Kapoor R, Miller D. Energy failure in multiple sclerosis and its investigation using MR techniques. J Neurol 2011; 258: 2113-2127.
40. Cambron M, D'Haeseleer M, Laureys G, Clinckers R, Debruyne J, Keyser JD. White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis. J Cereb Blood Flow Metab 2012; 32: 413-424.